Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Triple Flag Q3 net earnings rise year over year to USD 64.24 million; Q3 revenue climbs 14% year over year to USD 106.68 million

Triple Flag Q3 net earnings rise year over year to USD 64.24 million; Q3 revenue climbs 14% year over year to USD 106.68 million

BitgetBitget2026/11/03 22:45
  • Triple Flag Precious Metals’ Q3 2026 net earnings rose year over year to USD 64.24 million.
  • Revenue climbed 14% year over year to USD 106.68 million, largely driven by higher gold and silver prices.
  • Operating cash flow increased 13% year over year to USD 91.97 million, while gold equivalent ounces sold fell 7% to 25,030.
  • Management maintained 2026 guidance of 100,000–110,000 gold equivalent ounces, expecting volumes between the midpoint and high end.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Triple Flag Precious Metals Corp. published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs comments on AMD (AMD.US) Q3 performance: Data center CPU and GPU show strong performance, growth visibility for 2027 is clear

Goldman Sachs released a research report maintaining a "Buy" rating on AMD (AMD.US) with a 12-month target price of $675.

智通财经•2026/11/04 03:53

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs

AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.

智通财经•2026/11/04 02:51